Skip to content
Urban Fortune Service

Patients Coming Off Slimming Medications Put On Weight Four Times Faster Compared to People Using Diet and Exercise

Illustration of pharmaceutical syringe and scale
Obesity treatment often requires long-term strategies.

A recent study reveals that individuals who come off popular slimming jabs like Wegovy and Mounjaro can put back on reduced body mass far faster than those who halt traditional diet and exercise programs.

Findings released in a leading health publication shows that while obese individuals can lose a large proportion of their body weight while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month after stopping.

"People using such treatments should be cognizant of the risk of quick rebound weight gain when the therapy is stopped," cautioned researcher Dr. Susan Jebb.

This pace of recovery implies a reversion to starting weight within about one and a half years.

Analyzing Approaches

The research, which examined dozens of studies involving over 9,000 of patients, compared the effects of GLP-1 agonists with other pills.

Researchers point out that individuals who lose weight through dieting generally experience a more gradual weight regain—approximately 0.1 kg a month—post-intervention.

Explaining the Rapid Rebound

Nutrition scientists believe the mode of action of the injections explains the accelerated rebound.

The injections copy a natural hormone called GLP-1, which helps regulate appetite.

"Sustained high doses of the hormone concentrations far above than the body's typical production could lead to the body to produce less of its own natural hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this medication results in hunger is unsuppressed, making excessive eating far more likely."

An Ongoing Condition?

Health authorities recommend the jabs for individuals with weight-linked medical conditions, alongside prescribed lifestyle changes.

A number of clinicians contend that, considering the significant potential of weight regain, the treatment should be considered ongoing.

This opinion is echoed by pharmaceutical companies, who note that the findings "highlight the persistent character of obesity," similar to managing diseases like hypertension.

Patient Experiences

People who have come off the medication report a intense resurgence of hunger.

"It was like a trigger activating and you become extremely hungry," recalled a patient.

The struggle is worsened if users have not established lasting dietary or behavioural changes during treatment.

Widespread Interest

Survey data suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand being substantial.

  • Adoption is higher among women compared to males.
  • The 40s and 50s age group shows the highest usage rates.
  • A large proportion access the medications through private healthcare rather than public health services.

Ultimately, researchers caution that while the jabs are effective tools for weight loss, they are not a permanent solution and maintained weight loss relies on ongoing lifestyle changes.

RR
By

Randy Rowland

A seasoned financial strategist with a passion for helping individuals achieve their dreams through smart investments.

Urban Fortune Service

Type to search articles.